Orlando, Tuesday, -- This year's Digestive Disease Week meeting has provided a rich harvest of original work and expert opinion in the area of hepatobiliary and pancreatic disorders. Both ...
Impact of the COVID-19 pandemic on disease progression in patients with hepatobiliary and pancreatic cancer. Adjuvant tislelizumab combined with capecitabine for patients with biliary tract cancer ...
Zhejiang-Germany Interdisciplinary Joint Laboratory of Hepatobiliary-Pancreatic Tumor and Bioengineering has the following research output in the current window (1 January 2025 - 31 December 2025) of ...
Pancreatic cancer has a reputation for being one of the deadliest malignancies, in part because it is often diagnosed late and progresses quickly. While genetics and age play a role, a growing body of ...
The New York Times: Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
Markets Insider: Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial
Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial
There’s an ongoing uncertainty among experts about whether neoadjuvant therapy or surgery first is best for patients with operable pancreatic cancer. Here’s what we know.
National Geographic: This might be the biggest breakthrough in pancreatic cancer in decades
New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” ...
The Chosun Ilbo on MSN: Sudden diabetes onset may signal pancreatic cancer
The rationale for suspecting pancreatic cancer has become clear if diabetes suddenly develops or existing diabetes rapidly worsens without specific reasons such as weight gain or dietary changes. This ...